C
LOVE
vs
S
S&P TSX Composite Index (Canada)
Over the past 12 months, LOVE has significantly outperformed S&P TSX Composite Index (Canada), delivering a return of +138% compared to the S&P TSX Composite Index (Canada)'s +29% growth.
Stocks Performance
LOVE vs S&P TSX Composite Index (Canada)
Performance Gap
LOVE vs S&P TSX Composite Index (Canada)
Performance By Year
LOVE vs S&P TSX Composite Index (Canada)
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Cannara Biotech Inc
Glance View
Cannara Biotech, Inc. is a pharmaceutical company, which operates cannabis biotech facility. The company is headquartered in Montreal, Quebec. The company went IPO on 2019-01-14. The firm operates through its wholly owned subsidiaries, Cannara Biotech (Quebec) Inc. and Cannara Biotech (Valleyfield) Inc. Its segments include Indoor cannabis operations and Real estate operations. The Indoor cannabis operations segment includes the cultivation, processing and sale of dried cannabis and cannabis derivatives exclusively for the Quebec and Canadian market. The Real estate operations segment is related to the Farnham building. The Company, through ShopCBD.com Inc., operates an online e-commerce platform in the United States hemp-based Cannabidiol (CBD) market. The firm sells dried cannabis products to provincial retail distributors and other licensed producers across Canada through Cannara Biotech (Quebec) Inc. The company owns approximately two cultivation facilities based in Quebec spanning over 1,650,000 square feet.